Romeo Maciuca
Publications by Year
Research Areas
Asthma and respiratory diseases, Endoplasmic Reticulum Stress and Disease, Parkinson's Disease Mechanisms and Treatments, Inflammatory Bowel Disease, RNA regulation and disease
Most-Cited Works
- → Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study(2012)1,404 cited
- → Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies(2015)375 cited
- → Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double‐Blind, Phase III Study(2013)348 cited
- → A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)(2015)336 cited
- → Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease(2022)237 cited
- → Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: Results of a phase I, placebo‐controlled, double‐blind, dose‐escalation study(2012)183 cited
- → Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE(2015)154 cited
- → Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production(2014)122 cited
- → LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease(2023)100 cited
- → A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma(2016)97 cited